HAEMONETICS CORP - Common stock, $.01 par value per share (HAE)

CUSIP: 405024100

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common stock, $.01 par value per share
Shares outstanding
46,480,294
Total 13F shares
55,858,330
Share change
-265,230
Total reported value
$4,486,624,929
Put/Call ratio
96%
Price per share
$80.38
Number of holders
303
Value change
-$21,003,128
Number of buys
146
Number of sells
166

Quarterly Holders Quick Answers

What is CUSIP 405024100?
CUSIP 405024100 identifies HAE - HAEMONETICS CORP - Common stock, $.01 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) as of Q3 2024

As of 30 Sep 2024, HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) was held by 303 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,858,330 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, Capital Research Global Investors, WELLINGTON MANAGEMENT GROUP LLP, NEUBERGER BERMAN GROUP LLC, T. Rowe Price Investment Management, Inc., STATE STREET CORP, ROYCE & ASSOCIATES LP, GEODE CAPITAL MANAGEMENT, LLC, and Thrivent Financial for Lutherans. This page lists 304 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.